Single User License
INR 168550
Site License
INR 337100
Corporate User License
INR 505650

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Nasal Obstruction Global Clinical Trials Review, H1

Nasal Obstruction Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Nasal Obstruction Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Nasal Obstruction Global Clinical Trials Review, H1, 2015" provides an overview of Nasal Obstruction clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Obstruction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Nasal Obstruction 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials 18

Clinical Trials in E7 Countries by Trial Status 19

Clinical Trials by Phase 20

In Progress Trials by Phase 21

Clinical Trials by Trial Status 22

Clinical Trials by End Point Status 23

Unaccomplished Trials of Nasal Obstruction 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Nasal Obstruction Therapeutics Clinical Trials 28

Prominent Drugs 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Merck & Co., Inc. 30

Clinical Trial Overview of Merck & Co., Inc. 30

Zurita Laboratorio Farmaceutico Ltda 31

Clinical Trial Overview of Zurita Laboratorio Farmaceutico Ltda 31

Optinose US Inc. 32

Clinical Trial Overview of Optinose US Inc. 32

Farmoquimica S/A 33

Clinical Trial Overview of Farmoquimica S/A 33

Clinical Trial Overview of Top Institutes / Government 34

Eastern Virginia Medical School 34

Clinical Trial Overview of Eastern Virginia Medical School 34

HaEmek Medical Center 35

Clinical Trial Overview of HaEmek Medical Center 35

Hospital de Clinicas de Porto Alegre 36

Clinical Trial Overview of Hospital de Clinicas de Porto Alegre 36

Kerman Medical University 37

Clinical Trial Overview of Kerman Medical University 37

Massachusetts General Hospital 38

Clinical Trial Overview of Massachusetts General Hospital 38

Mayo Clinic 39

Clinical Trial Overview of Mayo Clinic 39

NHS Grampian 40

Clinical Trial Overview of NHS Grampian 40

Northern Health and Social Care Trust 41

Clinical Trial Overview of Northern Health and Social Care Trust 41

Norwegian University of Science and Technology 42

Clinical Trial Overview of Norwegian University of Science and Technology 42

Radboud University Nijmegen Medical Centre 43

Clinical Trial Overview of Radboud University Nijmegen Medical Centre 43

Five Key Clinical Profiles 44

Appendix 62

Abbreviations 62

Definitions 62

Research Methodology 63

Secondary Research 63

About GlobalData 64

Contact Us 64

Disclaimer 64

Source 64

List of Figures

Nasal Obstruction Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Nasal Obstruction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Nasal Obstruction Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Nasal Obstruction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Nasal Obstruction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15

Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18

Nasal Obstruction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Nasal Obstruction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20

Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21

Nasal Obstruction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Nasal Obstruction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Nasal Obstruction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Nasal Obstruction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Nasal Obstruction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Nasal Obstruction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Nasal Obstruction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

GlobalData Methodology 63

List of Tables

Nasal Obstruction Therapeutics, Global, Clinical Trials by Region, 2015* 7

Nasal Obstruction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Nasal Obstruction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Nasal Obstruction Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Nasal Obstruction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Nasal Obstruction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Nasal Obstruction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15

Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Nasal Obstruction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Nasal Obstruction to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18

Nasal Obstruction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19

Nasal Obstruction Therapeutics, Global, Clinical Trials by Phase, 2015* 20

Nasal Obstruction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21

Nasal Obstruction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22

Nasal Obstruction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23

Nasal Obstruction Therapeutics, Global, Terminated Clinical Trials, 2015* 24

Nasal Obstruction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Nasal Obstruction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Nasal Obstruction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Nasal Obstruction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Nasal Obstruction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 30

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Zurita Laboratorio Farmaceutico Ltda, 2015* 31

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Optinose US Inc., 2015* 32

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Farmoquimica S/A, 2015* 33

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2015* 34

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2015* 35

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2015* 36

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kerman Medical University, 2015* 37

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 38

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 39

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Grampian, 2015* 40

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Northern Health and Social Care Trust, 2015* 41

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2015* 42

Nasal Obstruction Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2015* 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Merck & Co., Inc.

Zurita Laboratorio Farmaceutico Ltda

Optinose US Inc.

Farmoquimica S/A

Nasal Obstruction Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Nasal Obstruction, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com